Q: I'm considering buying a 5% share in CC & would appreciate your input on the company. I'm concerned about the debt which was quite high last year.The debt is $2.6B with a net leveraged ratio of 1.8 times on a trailing 12 months basis. Is this coming down or increasing?
The businesses, all three, seem to be doing quite well.Do you agree?Will there be further share repurchases or is it finished.What is the EPS & the free cash flow based on the US tax reform? Is it a buy or should I pass on it?

Q: I acquired a small position in Chemours when it was split off from Dupoint. I have watched as it grows with great momentum. Do you think it wise to expand my holding to a full position or has it run a bit ahead of itself at this point? As always, thanks for the consistently great advise.

John

Q: Hello 5i, any insight you can provide on this US company would be appreciated.
Thank you!!
Dave